• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌中p16基因启动子异常高甲基化

Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.

作者信息

Hu Zhuo-ying, Tang Liang-dan, Zhou Qin, Xiao Lin, Cao Yi

机构信息

Department of Obstetrics and Gynecology, The First Affiliated Hospital, Chongqing Medical University, 1 Youyi Road, Chongqing, 400016, China.

出版信息

Tumour Biol. 2015 Mar;36(3):1487-91. doi: 10.1007/s13277-014-2632-3. Epub 2015 Jan 17.

DOI:10.1007/s13277-014-2632-3
PMID:25596080
Abstract

Previous studies demonstrated that the loss of function of the p16INK4A gene is mainly caused by the hypermethylation of p16 gene promoter; however, whether or not it is associated with the incidence of endometrial carcinoma (EC) remains unclear. In the current study, we conducted a meta-analysis to investigate the effects of p16 gene promoter hypermethylation on the incidence of EC. Detailed research publications were searched from Embase, PubMed, and ISI Web of Knowledge for composition in English or Chinese. The pooled data were collected and analyzed by Review Manager 5.2. Odds ratios (ORs) were calculated and summarized respectively. Six eligible studies, including 261 patients were selected and analyzed. The pooled OR was 0.42, test for overall effect, Z = 10.19, P < 0.0001, indicating that p16 gene promoter hypermethylation was significantly correlated with the EC patients. The results of our study strongly suggest that p16 gene promoter hypermethylation is correlated with an increased risk of EC. P16 gene promoter hypermethylation plays a critical role in endometrial carcinogenesis.

摘要

以往研究表明,p16INK4A基因功能缺失主要由p16基因启动子的高甲基化所致;然而,其是否与子宫内膜癌(EC)的发病相关仍不清楚。在本研究中,我们进行了一项荟萃分析,以探讨p16基因启动子高甲基化对EC发病的影响。从Embase、PubMed和ISI Web of Knowledge中检索了详细的研究出版物,以查找英文或中文文献。通过Review Manager 5.2收集并分析汇总数据。分别计算并汇总比值比(OR)。选择并分析了6项符合条件的研究,包括261例患者。汇总OR为0.42,总体效应检验Z = 10.19,P < 0.0001,表明p16基因启动子高甲基化与EC患者显著相关。我们的研究结果强烈表明,p16基因启动子高甲基化与EC风险增加相关。P16基因启动子高甲基化在子宫内膜癌发生中起关键作用。

相似文献

1
Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.子宫内膜癌中p16基因启动子异常高甲基化
Tumour Biol. 2015 Mar;36(3):1487-91. doi: 10.1007/s13277-014-2632-3. Epub 2015 Jan 17.
2
Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.CDKN2A/p16在子宫内膜癌中的临床病理意义及潜在药物靶点
Sci Rep. 2015 Aug 18;5:13238. doi: 10.1038/srep13238.
3
Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.日本患者子宫内膜癌发生过程中p16启动子区域的高甲基化
Anticancer Res. 2006 Mar-Apr;26(2A):851-6.
4
Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.hMLH-1和CDKN2A/p16基因在良性、癌前和恶性子宫内膜病变中的异常DNA高甲基化。
Eur J Gynaecol Oncol. 2009;30(3):267-70.
5
[Methylation and expression of the p16 gene in endometrial carcinoma].[子宫内膜癌中p16基因的甲基化与表达]
Zhonghua Zhong Liu Za Zhi. 2000 May;22(3):228-31.
6
p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.p16INK4A改变伴随子宫内膜癌中异常的蛋白免疫染色。
J Cancer Res Clin Oncol. 2003 Oct;129(10):589-96. doi: 10.1007/s00432-003-0482-2. Epub 2003 Aug 14.
7
Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.软组织平滑肌肉瘤中p16INK4a基因失活的机制:p16表达降低与启动子甲基化及预后不良相关。
J Pathol. 2003 Nov;201(3):487-95. doi: 10.1002/path.1419.
8
P16 alterations increase the metastatic potential of endometrial carcinoma.P16基因改变增加子宫内膜癌的转移潜能。
Gynecol Oncol. 2008 Nov;111(2):365-71. doi: 10.1016/j.ygyno.2008.07.037. Epub 2008 Sep 14.
9
Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.核p16蛋白表达缺失与启动子甲基化无关,但定义了一组预后不良的侵袭性子宫内膜癌亚组。
Clin Cancer Res. 2000 Jan;6(1):153-9.
10
p16 promoter hypermethylation is associated with increased breast cancer risk.p16 启动子超甲基化与乳腺癌风险增加相关。
Mol Med Rep. 2012 Oct;6(4):904-8. doi: 10.3892/mmr.2012.1001. Epub 2012 Jul 23.

引用本文的文献

1
Research Progress of DNA Methylation Markers for Endometrial Carcinoma Diagnosis.子宫内膜癌诊断中DNA甲基化标志物的研究进展
J Cancer. 2025 Jan 1;16(3):812-820. doi: 10.7150/jca.104214. eCollection 2025.
2
Research Progress of DNA Methylation in Endometrial Cancer.子宫内膜癌中 DNA 甲基化的研究进展。
Biomolecules. 2022 Jul 4;12(7):938. doi: 10.3390/biom12070938.
3
Papillary mucinous metaplasia: a distinct precursor of mucinous adenocarcinoma of the endometrium.乳头状黏液化生:子宫内膜黏液腺癌的一种独特前驱病变。

本文引用的文献

1
Genome-wide age-related DNA methylation changes in blood and other tissues relate to histone modification, expression and cancer.血液和其他组织中与年龄相关的全基因组 DNA 甲基化变化与组蛋白修饰、表达和癌症有关。
Carcinogenesis. 2014 Feb;35(2):356-64. doi: 10.1093/carcin/bgt391. Epub 2013 Nov 28.
2
Efficacy of anti-leishmania therapy in visceral leishmaniasis among HIV infected patients: a systematic review with indirect comparison.抗利什曼原虫治疗 HIV 感染患者内脏利什曼病的疗效:一项系统评价与间接比较。
PLoS Negl Trop Dis. 2013 May 2;7(5):e2195. doi: 10.1371/journal.pntd.0002195. Print 2013.
3
Cancer statistics, 2013.
Int J Clin Exp Pathol. 2022 Feb 15;15(2):83-87. eCollection 2022.
4
Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses.与卵巢癌相关因素的调查:系统评价和荟萃分析的伞状综述。
J Ovarian Res. 2021 Nov 11;14(1):153. doi: 10.1186/s13048-021-00911-z.
5
Gene Promoter Methylation in Endometrial Carcinogenesis.子宫内膜癌发生过程中的基因启动子甲基化
Pathol Oncol Res. 2019 Apr;25(2):659-667. doi: 10.1007/s12253-018-0489-2. Epub 2018 Nov 14.
6
Aberrant Methylation of MGMT Promoter in HNSCC: A Meta-Analysis.头颈部鳞状细胞癌中MGMT启动子的异常甲基化:一项荟萃分析。
PLoS One. 2016 Sep 22;11(9):e0163534. doi: 10.1371/journal.pone.0163534. eCollection 2016.
7
Association between P16INK4a Promoter Methylation and Ovarian Cancer: A Meta-Analysis of 12 Published Studies.P16INK4a基因启动子甲基化与卵巢癌的关联:对12项已发表研究的荟萃分析
PLoS One. 2016 Sep 20;11(9):e0163257. doi: 10.1371/journal.pone.0163257. eCollection 2016.
8
miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells.微小RNA-101通过逆转PRDM16启动子的低甲基化来破坏星形细胞瘤细胞的线粒体功能。
Oncotarget. 2016 Jan 26;7(4):5007-22. doi: 10.18632/oncotarget.6652.
9
Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.CDKN2A/p16在子宫内膜癌中的临床病理意义及潜在药物靶点
Sci Rep. 2015 Aug 18;5:13238. doi: 10.1038/srep13238.
癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
4
Molecular pathology of endometrial carcinoma.子宫内膜癌的分子病理学。
Histopathology. 2013 Jan;62(1):111-23. doi: 10.1111/his.12053.
5
OSAT: a tool for sample-to-batch allocations in genomics experiments.OSAT:基因组学实验中样本到批次分配的工具。
BMC Genomics. 2012 Dec 10;13:689. doi: 10.1186/1471-2164-13-689.
6
Endometrial carcinoma: molecular alterations involved in tumor development and progression.子宫内膜癌:肿瘤发生发展过程中涉及的分子改变。
Oncogene. 2013 Jan 24;32(4):403-13. doi: 10.1038/onc.2012.76. Epub 2012 Mar 19.
7
Status and significance of CpG island methylator phenotype in endometrial cancer.子宫内膜癌中 CpG 岛甲基化表型的现状和意义。
Gynecol Obstet Invest. 2011;72(3):183-91. doi: 10.1159/000324496. Epub 2011 Sep 27.
8
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.子宫内膜癌发生中的表观遗传学指纹:子宫局部癌变假说。
Cancer Biol Ther. 2011 Sep 1;12(5):447-57. doi: 10.4161/cbt.12.5.15963.
9
Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma.比较分析 HCV 阳性肝癌患者肿瘤组织和非肿瘤组织启动子甲基化和基因表达终点。
Mutat Res. 2010 Oct 13;692(1-2):26-33. doi: 10.1016/j.mrfmmm.2010.07.013. Epub 2010 Aug 22.
10
The association between metabolic abnormality and endometrial cancer: a large case-control study in China.代谢异常与子宫内膜癌的相关性:中国一项大型病例对照研究。
Gynecol Oncol. 2010 Apr;117(1):41-6. doi: 10.1016/j.ygyno.2009.12.029. Epub 2010 Jan 22.